JPRN-UMIN000017232已完成未知
A phase II study of concurrent weekly carboplatin and paclitaxel combined with definitive radiotherapy for advanced-stage cervical cancer. - A phase II study of concurrent weekly carboplatin and paclitaxel combined with definitive radiotherapy for advanced-stage cervical cancer.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •FIGO stage Ia-IIIa cervical cancer
研究者
相似试验
已完成
不适用
A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung CancerJPRN-UMIN000023802Hirosaki University28
已完成
2 期
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer using MNASquamous cell lung cancerJPRN-UMIN000012051OSAKA-LCSG30
已完成
不适用
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancerJPRN-UMIN000010324orth Japan Lung Cancer Study Group35
已完成
2 期
Phase 2 study of carboplatin and weekly nab-paclitaxel for elderly squamous cell lung cancersquamous cell lung cancerJPRN-UMIN000012025Osaka City General Hospital35
招募中
2 期
Phase II study of Carboplatin and alternate-day administrations of TS-1 in patients with advanced squamous cell lung cancer.Squamous cell carcinoma of the lungJPRN-UMIN000009308Kyoto Thoracic Oncology Research Group35